Systemic shifts toward lifelong cardiometabolic prevention address gaps in managing cardiovascular disease and type 2 diabetes
Barriers to heart health care are not a lack of science
This narrative review examines the barriers to implementing effective cardiometabolic prevention and the clinical utility of specific risk a…
Experts find that the gap between medical knowledge and patient care for heart disease is caused by social and economic factors, not a lack …
Antidiabetic drugs and gut microbiota interact to influence treatment efficacy and tolerability in metabolic syndrome
Gut bacteria may influence how well diabetes drugs work
This narrative review explores how gut microbiota dysbiosis contributes to metabolic syndrome and type 2 diabetes. It synthesizes evidence t…
Your gut bacteria might be the secret reason why some people respond better to diabetes medications than others.
Butyrate and fecal acetate levels are significantly lower in patients with type 2 diabetes
Short Chain Fatty Acids Linked to Type 2 Diabetes Levels
This meta-analysis of 7,371 participants analyzed short-chain fatty acid (SCFA) levels in individuals with normal glucose tolerance, prediab…
Lower levels of specific fatty acids in the gut are linked to type 2 diabetes and prediabetes in a large review of over 7,000 people.
Older age, longer diabetes duration, and higher HbA1c levels associate with sarcopenia in type 2 diabetes
Several Factors Linked to Muscle Loss in Type 2 Diabetes
This meta-analysis of 4,727 patients identifies several clinical factors associated with sarcopenia in older patients with type 2 diabetes. …
Older patients with type 2 diabetes may face higher risks of muscle loss linked to age, longer disease duration, and higher blood sugar leve…
Short-bout accumulated physical activity reduces mean glucose in adults with type 2 diabetes
Short bursts of activity may lower blood sugar in diabetes
This meta-analysis of 175 participants indicates that short-bout accumulated physical activity and sedentary-break interventions reduce mean…
Short bursts of physical activity and frequent breaks from sitting may help lower average blood sugar levels for adults with type 2 diabetes…
Ecnoglutide improves glycemic control and reduces body weight in adults with type 2 diabetes
Ecnoglutide Shows Promise for Type 2 Diabetes Management
This meta-analysis evaluated the efficacy of ecnoglutide in adults with type 2 diabetes compared to placebo and dulaglutide. The findings in…
Ecnoglutide may help manage blood sugar and reduce body weight in adults with type 2 diabetes, though more large-scale studies are needed.
Laparoscopic excision of a hypervascular mass confirms hyaline vascular-type unicentric Castleman disease in a patient with diabetes
Surgery for a rare mass helps a woman with diabetes
This case report describes a 26-year-old woman with Type 2 Diabetes Mellitus and a hypervascular mass. Surgical excision confirmed a diagnos…
A 26-year-old woman with Type 2 Diabetes had a rare growth near her pancreas that doctors successfully removed.
OSA Tied to Poorer Glucose Control in Type 2 Diabetes
Sleep Apnea Linked to Poorer Blood Sugar Control in Diabetes
Obstructive sleep apnoea is consistently linked to worse glucose control and insulin resistance in people with type 2 diabetes or prediabete…
People with Type 2 Diabetes and sleep apnea may face harder blood sugar management and higher insulin resistance.
Survodutide Improves Beta Cell Function and Insulin Sensitivity in T2D and Obesity
Trial shows survodutide improves insulin sensitivity and beta-cell function
Survodutide demonstrates significant improvements in beta-cell function and insulin sensitivity across both T2D and overweight populations.
A new medication called survodutide may improve how the body handles insulin and supports the cells that produce it for people with type 2 d…
Comparative Efficacy of GLP-1 Receptor Agonists for Adolescent Obesity and Type 2 Diabetes
Trial shows different GLP-1 medications impact weight and blood sugar
A network meta-analysis evaluates GLP-1 receptor agonists in adolescents, identifying varying degrees of efficacy across weight, glucose, an…
New analysis of GLP-1 medications shows varying results for weight loss and blood sugar control in adolescents with obesity and type 2 diabe…
SGLT2 inhibitors not tied to gastrointestinal cancer risk in type 2 diabetes meta-analysis
SGLT2 inhibitors show no link to gastrointestinal cancer risk
This meta-analysis of 48,765 patients with type 2 diabetes found no significant association between SGLT2 inhibitor use and overall or site-…
New data suggests that SGLT2 inhibitors, a common treatment for type 2 diabetes, do not increase the risk of various gastrointestinal cancer…
CareAide mHealth application improves medication adherence and quality of life in type 2 diabetes
Pharmacist-led mobile app improves medication habits for type 2 diabetes
This multicentre randomized controlled trial of 663 patients with type 2 diabetes found that the CareAide mHealth application significantly …
A new mobile app led by pharmacists helps people with type 2 diabetes stay on track with their medications and improve their quality of life…
Research across Diabetes
Related studies from across the Diabetes family.
Clopidogrel monotherapy reduces MACCE risk in patients with diabetes compared to aspirin monotherapy
Trial shows clopidogrel lowers heart risks for patients with diabetes
This multicenter randomized controlled trial of 5,506 patients who underwent percutaneous coronary intervention found that clopidogrel monot…
A new analysis shows that clopidogrel may be more effective than aspirin at preventing heart attacks and strokes in patients with diabetes.
Diabetes increases risk of target vessel failure and adverse events during percutaneous coronary intervention
Trial shows higher risks for patients with diabetes after heart procedures
Researchers evaluated the impact of diabetes on outcomes following percutaneous coronary intervention, comparing optical coherence tomograph…
Patients with diabetes face higher risks of heart complications after certain procedures, even when using advanced imaging technology.
Fragmented patient-reported outcome measures currently characterize the clinical landscape of type 3c diabetes
Mapping how patients experience life with type 3c diabetes
This scoping review of 40 reports maps standardized patient-reported outcome measures (PROMs) in adults with type 3c diabetes. Findings indi…
Living with type 3c diabetes after a total pancreatectomy often impacts physical function and general health, but more consistent tracking i…
Metabolomics profiling identifies amino acid and lipid metabolism alterations in patients with diabetes mellitus
Metabolomics Profiling Identifies Key Markers for Diabetes Management
This systematic review of 188 studies examines metabolomics profiling to identify metabolite signatures associated with diabetes and glucose…
New research highlights how metabolomics can identify specific patterns in amino acids and lipids to help manage and predict diabetes outcom…
CABG reduces all-cause death and repeat revascularisation risk in patients with diabetes and CKD
CABG Shows Lower Risk for Patients with Diabetes and CKD
This systematic review and meta-analysis of 10594 patients with multivessel coronary disease and multiple long-term conditions found CABG fa…
Surgery may offer better outcomes than other procedures for patients with heart disease who also have diabetes and chronic kidney disease.
T1D MAPS polygenic score improves discrimination in non-EUR populations compared to T1D GRS2
New genetic scores improve risk prediction for type 1 diabetes
This meta-analysis evaluates the predictive performance of multiple polygenic scores for Type 1 Diabetes. The T1D MAPS score demonstrated si…
A new genetic scoring system shows better accuracy in predicting type 1 diabetes risk for people of diverse backgrounds.
Only 10% of Chinese adults with diabetes demonstrate good practices for diabetic foot care
Most people with diabetes lack good foot care practices
This systematic review and meta-analysis of 6,124 Chinese adults with diabetes identifies significant gaps in foot care knowledge and practi…
A large study of over 6,000 people shows that while many have positive attitudes toward foot care, very few actually perform good daily prac…
Depressive disorder in patients with diabetes increases all-cause mortality and metabolic complications
Depression Linked to Higher Mortality Risk in People with Diabetes
This meta-analysis of patients with diabetes and co-occurring depressive disorder found a 1.30 increased risk of all-cause mortality compare…
People with both diabetes and depression may face a higher risk of death and serious health complications compared to those with diabetes al…
Clopidogrel monotherapy reduces bleeding risk to 2.1% versus 3.2% in patients with acute coronary syndromes
Trial shows clopidogrel alone reduces bleeding risk after heart procedures
This prespecified subgroup analysis of a randomized controlled trial involving 7758 patients with acute coronary syndromes found that clopid…
Patients with heart conditions may face fewer bleeding risks by switching to clopidogrel alone after a period of dual therapy.
Exercise training increases circulating s-Klotho levels in adults with CKD and sarcopenia
Exercise Training Increases Klotho Levels in People with Kidney Disease
This meta-analysis of 893 participants evaluated the impact of various exercise modalities on s-Klotho and FGF23 levels. The analysis found …
Regular exercise training, including resistance and high-intensity intervals, may increase Klotho levels in adults with kidney disease and d…
Functional creams and urea-containing formulations significantly reduce xerosis severity in patients with diabetes
Functional creams with urea improve dry skin in people with diabetes
This meta-analysis evaluates the efficacy of functional creams versus standard base formulations for treating foot xerosis in adults with di…
Specialized creams containing urea can significantly improve dry skin and hydration for adults living with diabetes.
rs741301 polymorphism is associated with reduced susceptibility to diabetic nephropathy in meta-analysis
Genetic Marker Linked to Lower Risk of Diabetic Kidney Disease
This meta-analysis of 880 individuals with diabetes mellitus and 1008 individuals with diabetic nephropathy found that the rs741301 polymorp…
A specific genetic variation, known as the rs741301 polymorphism, may be linked to a lower risk of developing kidney damage in people with d…
Questions about Type 2 Diabetes
Do GLP-1RAs help improve walking distance for those with diabetes and Peripheral Artery Disease?
Yes, GLP-1 receptor agonists (liraglutide, semaglutide) improve walking distance in people with type 2 diabetes and peripheral artery disease, based on a 2025 meta-analysis of randomized trials.
Full answer →What common genes link Polycystic Ovary Syndrome and type 2 diabetes according to recent studies?
Recent studies link PCOS and type 2 diabetes through shared genetic variants, notably the insulin gene VNTR and epigenetic changes in metabolism-related genes.
Full answer →What are the standard treatment options available for someone with Type 2 Diabetes?
Standard treatment for type 2 diabetes includes lifestyle changes (diet, exercise), metformin, other medications like GLP-1 agonists (e.g., semaglutide, tirzepatide), and sometimes insulin, along with monitoring blood sugar and managing cardiovascular risk.
Full answer →What are the best lifestyle changes to manage Type 2 Diabetes effectively?
A Mediterranean diet, regular physical activity, weight loss, and digital health tools can effectively manage type 2 diabetes, with medication support as needed.
Full answer →All Type 2 Diabetes Articles
- Systemic shifts toward lifelong cardiometabolic prevention address gaps in managing cardiovascular disease and type 2 diabetes
- Antidiabetic drugs and gut microbiota interact to influence treatment efficacy and tolerability in metabolic syndrome
- Butyrate and fecal acetate levels are significantly lower in patients with type 2 diabetes
- Laparoscopic excision of a hypervascular mass confirms hyaline vascular-type unicentric Castleman disease in a patient with diabetes
- Short-bout accumulated physical activity reduces mean glucose in adults with type 2 diabetes
- Older age, longer diabetes duration, and higher HbA1c levels associate with sarcopenia in type 2 diabetes
- Ecnoglutide improves glycemic control and reduces body weight in adults with type 2 diabetes
- OSA Tied to Poorer Glucose Control in Type 2 Diabetes
- Survodutide Improves Beta Cell Function and Insulin Sensitivity in T2D and Obesity
- Comparative Efficacy of GLP-1 Receptor Agonists for Adolescent Obesity and Type 2 Diabetes
- CareAide mHealth application improves medication adherence and quality of life in type 2 diabetes
- Exercise interventions improve metabolic flux and fatty acid oxidation in Type 2 Diabetes
- SGLT2 inhibitors not tied to gastrointestinal cancer risk in type 2 diabetes meta-analysis
- Thiazolidinediones increase bladder cancer risk while SGLT2 inhibitors show potential protective effects in Type 2 Diabetes
- Evaluating Glycemic Control and Weight Reduction of SGLT2 Inhibitors Versus DPP-4 Inhibitors
- Higher Triglyceride-glucose index is associated with increased risk of diabetic peripheral neuropathy
- NT-proBNP and cTnI as Prognostic Biomarkers in Type 2 Diabetes Patients
- Alert-based CDS increases UACR testing from 11.5% to 36.0% in patients with type 2 diabetes
- GLP-1 receptor agonists reduce MACE (HR 0.69) and all-cause mortality (HR 0.67) in Type 2 Diabetes
- Early time-restricted eating and bright light therapy protocol for insulin-independent type 2 diabetes
- Tirzepatide reduces MACE in adults with Type 2 Diabetes and obesity (OR 0.87)
- Low fat-free mass metrics are associated with increased risk of weight-related metabolic complications
- High-risk adiposity and inflammation trajectories correlate with significantly increased risk of incident Type 2 Diabetes
- Lithium-associated nephrogenic diabetes insipidus may cause severe postoperative hypernatremia and polyuria
- Magnesium oxide results in modest, non-significant HbA1c reduction in Type 2 Diabetes
- Combined aerobic-resistance training provides superior metabolic benefits for obese patients with type 2 diabetes
- Continuous ancestry representation boosts power in multi-ancestry meta-analysis for type 2 diabetes
- Elastic-band resistance training improves HbA1c and fasting plasma glucose in adults with type 2 diabetes
- Discharge planning for diabetes is multicomponent but lacks consistent outcomes and long-term follow-up
- Allostatic load serves as a predictor of surgical outcomes and explains socioeconomic disparities
- Pharmacist-led medication therapy management improves adherence and glycemic control in a patient with complex T2DM
- Pharmacist-integrated collaborative outpatient care reduces systolic blood pressure by 7.11 mm Hg in CKM populations
- Medically tailored groceries reduce HbA1c by 0.40 points in Medicaid-insured adults with type 2 diabetes
- Tirzepatide reduces hypertension risk but increases hypotension risk compared to semaglutide in T2DM and obesity
- Evaluation of Once Weekly Subcutaneous Zenagamtide for Management of Type 2 Diabetes
- Poor glycemic control in Type 2 Diabetes is associated with lower FEV1 and FVC volumes
- Structured education programs reduce HbA1c and multiple cardiometabolic risk factors in Type 2 Diabetes
- Glucagon-like peptide-1 receptor agonists associated with reduced Parkinson's disease risk in type 2 diabetes
- SGLT2 inhibitors raise hematocrit by 2.29% and hemoglobin by 0.51 g/dL in type 2 diabetes
- Tirzepatide reduces inflammatory markers and improves metabolic biomarkers in patients with obesity
- Psoriasis patients with moderate to severe disease show higher prevalence of type 2 diabetes
- BCAA metabolism modulation may improve insulin sensitivity and alleviate metabolic inflammation in Type 2 Diabetes
- 4-year lifestyle intervention cuts type 2 diabetes risk by 46% in post-GDM women
- Polypharmacy and insulin therapy significantly increase hypoglycemia odds in adults with type 2 diabetes
- Multidimensional CHW intervention reduces HbA1c by 1.0 percentage points in patients with type 2 diabetes
- Park visits and moderate-to-vigorous physical activity are associated with lower depressive symptoms
- COPD patients have higher odds of diabetes mellitus with an adjusted OR of 1.39
- SGLT2 inhibitors significantly reduce dementia risk in patients with type 2 diabetes
- Steviol glycosides serve as sucrose substitutes, but metabolic benefits need human validation
- GLP-1 receptor agonists associated with favorable cardiovascular outcomes in adults with Type 2 Diabetes
- Contextual adaptation and multi-level factors influence translation of dietary interventions for type 2 diabetes
- Time-restricted eating reduces body weight, BMI, and HbA1c in adults with type 2 diabetes
- Digital wearables support exercise self-management in type 2 diabetes via six behavior pathways
- AML infiltration of bile duct identified as primary cause of acute pancreatitis in case report
- Undiagnosed Type 2 Diabetes prevalence of 6.67% among adults in South Asia
- Face-to-face DSME produces approximately 1.3% HbA1c reduction at 30 weeks in type 2 diabetes
- High-intensity interval training associated with -0.73% HbA1c reduction in adults with type 2 diabetes
- Culturally tailored self-management interventions significantly decrease HbA1c levels in people with type 2 diabetes
- GLP-1 RA exposure in early pregnancy not significantly tied to hypertensive disorders
- mHealth apps reduce HbA1c by 0.39% in type 2 diabetes across 19 RCTs
- Oral-health promotion improves outcomes for adults with type 2 diabetes when guidance is provided
- OSAS not significantly tied to diabetic retinopathy overall, but risk doubles in Asian subgroups
- Proposed pathway for systematic MASLD/MASH assessment in type 2 diabetes
- Four specific miRNAs in extracellular vesicles satisfy high-tier causality for metabolic and inflammatory regulation
- Metabolic surgery review outlines framework for T2DM and obesity management
- SGLT2 inhibitors and GLP-1 receptor agonists show similar MACE reduction in type 2 diabetes
- SGLT2 inhibitors reduce body fat without significant impacts on skeletal muscle mass in type 2 diabetes
- Incretin-based weight loss lower in type 2 diabetes trials, but confounded by demographics
- Insulin resistance and hyperinsulinemia drive bidirectional links between biological aging and age-related chronic diseases
- Vitamin D deficiency is prevalent among African patients with Type 2 Diabetes and higher HbA1c
- GLP-1 receptor agonists and tirzepatide provide cardiovascular benefits across multiple clinical scenarios
- GLP-1 Receptor Agonists Associated with Reduced Cancer Risk in Patients with Type 2 Diabetes
- Specific gut microbiota taxa are associated with the presence of diabetic retinopathy in T2DM patients
- Bibliometric Analysis Mapping the Evolution of Stem Cell Therapies for Diabetes Management
- Exercise ameliorates both type 1 and type 2 diabetes through multiple mechanisms
- Liraglutide reduces stroke recurrence from 18.1% to 5.8% in patients with high insulin resistance
- Dapagliflozin plus pioglitazone reduces HbA1c by 0.49% and improves liver fat content in T2DM
- Unified cardiometabolic disease framework links T2DM, ASCVD, HFpEF, MASLD, hypertension, and CKD via shared pathophysiology
- GQD plus metformin significantly reduces FPG and 2hPG in adults with Type 2 Diabetes
- Mediterranean and DASH diets consistently support mitigation of cardiometabolic risk in metabolic syndrome patients
- Orforglipron Demonstrates Superior Glycaemic Control Over Dapagliflozin in Type 2 Diabetes
- Tirzepatide Efficacy and Safety for Managing Type 2 Diabetes in Chinese Patients
- AI models demonstrate high accuracy in predicting progression from Gestational Diabetes to Type 2 Diabetes
- Prediction models demonstrate high accuracy for identifying progression from prediabetes to Type 2 Diabetes Mellitus
- Cagrilintide-semaglutide reduces HbA1c by up to 2.33% in adults with type 2 diabetes
- Ubiquitination modifications by E3 ligases and DUBs form tissue-specific regulatory networks in Type 2 Diabetes
- Oral small-molecule GLP-1RAs reduce body weight by 3.93 and HbA1c by 0.94
- Patients with cardiovascular diseases show measurable prevalence of active cancer across multiple conditions
- Health literacy is moderately associated with improved self-care behaviors in patients with multiple chronic diseases
- Gut microbiota may influence metabolic response to GLP-1 receptor agonists in obesity and type 2 diabetes
- Two-year exercise training improves bone mineral density and trabecular bone score in type 2 diabetes
- Metabolic Dysfunction-Associated Steatotic Liver Disease prevalence reaches 56.9% among diabetic adults in India
- Mobile-ecological momentary assessment shows 70% compliance rate among adolescents and young adults with diabetes
- Canagliflozin mitigates increased cardiovascular risk from low-normal sodium intake in type 2 diabetes and CKD
- Metabolic and bariatric surgery achieves 70% steatohepatitis remission in patients with MAFLD
- Combined FGF-21 and GDF-15 show high diagnostic accuracy for insulin resistance in type 2 diabetes
- Pooled prevalence of diabetic kidney disease among Brazilian adults is 27.06% across 46 studies
- Initial dual oral therapy improves HbA1c target achievement in early stage type 2 diabetes
- CHGZGJT combined with conventional treatment improves HbA1c, fasting glucose, and lipid profiles in Type 2 Diabetes
- Finerenone reduces mortality and heart failure risk (HR 0.644) in post-AMI patients
- Combined exercise interventions significantly reduce glycated hemoglobin and fasting blood glucose in type 2 diabetes
- Incretin-based therapies outperform placebo for glycemic control and weight loss in type 2 diabetes
- General medical management improves medication adherence and lifestyle outcomes in older adults with type 2 diabetes
- Hyperuricemia affects 22% of type 2 diabetes patients in global meta-analysis
- Retatrutide Demonstrates Dose Dependent Glycemic Control and Weight Loss in Type 2 Diabetes
- Untreated glucose intolerance in pregnancy linked to postpartum metabolic dysfunction similar to treated GDM
- Once-weekly basal insulin improves HbA1c by 0.09% and time in range over daily regimens
- Resveratrol supplementation significantly reduces LDL-C but lacks consistent impact on glycemic indices in type 2 diabetes
- SGLT2 inhibitors associated with lower all-cause mortality in heart transplant recipients with type 2 diabetes
- Single-incision sleeve plus bypass shows short-term safety and metabolic improvement in 3 patients with obesity and T2DM
- Transcriptomic analysis identifies 337 high-confidence genes associated with Type 2 Diabetes in human pancreatic islets
- SGLT2 inhibitors provide robust prognostic benefits in heart failure with inconsistent results in post-myocardial infarction settings
- Metformin is associated with higher lactate concentrations during exercise in adults with prediabetes and type 2 diabetes
- Semaglutide reduces risk of kidney decline or death in type 2 diabetes and CKD
- Preoperative comorbidities linked to reduced weight loss after metabolic and bariatric surgery in adults
- GLP-1 receptor agonists may reduce cognitive decline in type 2 diabetes patients with dementia
- Evolocumab reduces cardiovascular events in diabetes without known atherosclerosis
- Pancreaticoduodenectomy alters GLP-1 and GIP responses, exploratory meta-analysis finds
- Long-term voglibose use likely caused leukopenia in a 71-year-old man with type 2 diabetes
- scFv-based biologics show potential for immunomodulation in type 1 and type 2 diabetes
- Insulin degludec/liraglutide ranks highest for HbA1c reduction with SUCRA value of 89.4%
- Metabolic subtypes identify Japanese adults with prediabetes at highest or lowest T2D risk
- Eating later in the biological day is associated with impaired glucose regulation and reduced insulin sensitivity
- 37 loci linked to gestational diabetes, 7 novel, in large multi-ancestry meta-analysis
- AI-driven cardiovascular risk prediction in type 2 diabetes shows promise but bias and lack of diversity limit clinical use
- GLP-1 receptor agonists show no increased ocular disorder risk in type 2 diabetes meta-analysis
- GLP-1RAs show lower risk of serious liver events compared with DPP-4 inhibitors in adults with type 2 diabetes
- Real-time CGM improved HbA1c versus SMBG in adults with type 2 diabetes on basal insulin and modern therapies
- Sitagliptin and liraglutide superior for CGM targets in type 2 diabetes
- Thiazolidinediones show lower hepatocellular carcinoma risk than DPP-4 inhibitors, GLP-1RAs, insulin, and sulfonylureas in this network meta-analysis
- SGLT2 inhibitor use associated with increased diabetic ketoacidosis risk, especially with elevated HbA1c
- Paternal metformin use during spermatogenesis shows no increased risk for major congenital malformations in over 11 000 children across five countries
- Resistance training reduces hemoglobin A1c by 0.62% and systolic blood pressure by 3.91 mmHg in type 2 diabetes
- Multicomponent behavioral interventions show sustained HbA1c reduction in type 2 diabetes
- Greater weight loss and supervised exercise reduce diabetes risk in adults with prediabetes
- Lifestyle programs show no significant diabetes incidence reduction in 14 studies of at-risk individuals
- Trans fatty acids from dairy foods show no increased cardiometabolic risk in systematic review and meta-analysis
- SGLT2 and dual SGLT1/2 inhibitors reduce cardiovascular death or heart failure hospitalization risk in type 2 diabetes patients
- Triple oral therapy with metformin, SGLT-2, and DPP-4 inhibitors lowers HbA1c better than dual regimens in adults with type 2 diabetes
- Natural polysaccharides enhance insulin sensitivity and protect pancreatic beta-cells in type 2 diabetes
- Probiotics, synbiotics, and berberine modestly lower fasting glucose and HbA1c in type 2 diabetes
- Women with Type 1 Diabetes have a 2.10 times higher risk of female sexual dysfunction compared to age-matched controls
- Systematic review and meta-analysis of tirzepatide effects on HbA1c and weight in adults with type 2 diabetes
- Network meta-analysis compares exercise types for glycemic control in type 2 diabetes
- Genetic analysis links GLP-1 agonism to pancreatitis risk and sarcopenia in large cohorts
- Meta-analysis identifies rare gene-trait associations across 1.2 million individuals in global biobanks
- Systematic review and meta-analysis of lifestyle interventions for Type 2 Diabetes in West Africa
- Review of lifestyle factors linked to Type 2 Diabetes risk in Qatar
- Meta-analysis finds higher intrapancreatic fat in type 2 diabetes
- CGM may boost treatment satisfaction in type 2 diabetes, but other outcomes unclear
- Narrative review proposes FISI tools for metabolic syndrome and diabetes management across the life cycle
- Case report and review of literature on acute NSTEMI after fluorescein angiography in a 76-year-old woman
- Systematic review of curcumin with piperine for metabolic and cardiometabolic conditions
- Meta-analysis of Mendelian randomization suggests GLP-1 receptor agonism lowers vascular dementia risk
- Meta-analysis: Resistance training improves vascular function in type 2 diabetes
- Review of GLP-1RAs in Type 2 Diabetes and Atherosclerosis Mechanisms
- Meta-analysis of blood pressure levels and outcomes in type 2 diabetes participants
- Systematic review and meta-analysis on VR for Type 2 Diabetes management
- Pediatric Gut Microbiome Links to Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes
- Network meta-analysis compares bexagliflozin efficacy and safety with other SGLT2 inhibitors in type 2 diabetes
- Systematic review and meta-analysis of HIIT versus MICT for Type 2 Diabetes outcomes
- Meta-analysis of GWAS in Native Hawaiians and Polynesians identifies 25 trait loci for diabetes and obesity traits
- Systematic review of 88 observational studies on missing data reporting in T2DM-MCI research
- Meta-analysis finds Type 2 diabetes linked to poorer survival in solid tumor patients on immune checkpoint inhibitors
- Network meta-analysis compares glucose-lowering therapies for heart failure with reduced ejection fraction and type 2 diabetes
- Systematic Review and Meta-Analysis of Subcutaneous CGM in Elective Surgery
- Systematic review of saponins for type 2 diabetes and its complications
- Digital Health Interventions Show Mixed Results for Cardiovascular Risk Reduction in Type 2 Diabetes Patients Across Weight Categories
- INSTI switching linked to higher metabolic risk in people with HIV
- Tirzepatide improves standard and intensive therapeutic target attainment versus semaglutide in adults with type 2 diabetes
- Personalized diabetes texting with peer support improved glycemic control and remission rates in type 2 diabetes patients
- Afternoon/Evening Exercise May Lower Blood Pressure More Than Morning Exercise: Meta-Analysis
- Systematic review and meta-analysis links Mediterranean diet to improved cardiometabolic markers
- Text messaging plus educational materials improves healthy eating in uncontrolled diabetes
- Systematic review and meta-analysis links Type 2 Diabetes to higher fracture risk across multiple anatomical sites
- Fasting plasma glucose shows higher diagnostic accuracy than HbA1c for undiagnosed diabetes in adults
- Review of NHANES data links metformin use to lower mortality and inflammatory markers in type 2 diabetes
- A 1-month nudge-based dietary intervention increased daily step counts by 1105 steps at 3 months in adults with type 2 diabetes
- Mobile app plus group sessions showed feasibility in Malaysian women with gestational diabetes
- Oral Sodium Butyrate Reduces Weight in Overweight Adults Without Diabetes
- Essential phospholipids reduced hepatic steatosis and improved HbA1c in patients with MASLD and type 2 diabetes over 6 months
- Reversion of Prediabetes to Normoglycemia Linked to 68% Lower Diabetes Risk
- Ecnoglutide Reduces HbA1c and Body Weight in Type 2 Diabetes: Meta-Analysis
- Meta-analysis finds GLP-1RA plus SGLT2i reduces UACR in type 2 diabetes with kidney disease
- Systematic review and meta-analysis of hypoglycaemia risk prediction models in type 2 diabetes
- GLP-1RAs reduce weight and HbA1c in severe mental illness with low discontinuation rates
- Meta-Analysis Identifies Risk Factors for Adverse Outcomes in MINOCA Patients
- Narrative review discusses pharmacological and lifestyle interventions for type 2 diabetes and psychological health
- Guideline narrative review discusses diabetes risks from immunosuppressive therapy in kidney transplant recipients
- Baseline anti-GIP antibody levels associate with future diabetes-range glycemia in health checkup cohort
- Narrative review examines multimorbidity impact on sepsis morbidity and mortality outcomes
- Review of miRNA associations with high-risk diabetes profiles in midlife women
- Baseline vitamin D levels linked to semaglutide glycemic and weight outcomes in type 2 diabetes
- GenMetS polygenic score association with cardiometabolic risk in Asian populations
- Semaglutide high dose for weight reduction in people with Type 2 Diabetes
- Individual-participant data meta-analysis shows blood-pressure lowering reduces cardiovascular risk in CKD and non-CKD populations
- Machine learning model improves early detection of occult diabetic kidney disease in hospitalized patients
- High LDL-C to HDL-C ratio linked to cardiovascular events in type 2 diabetes with retinopathy
- Observational study suggests multi-omic scores improve Type 2 Diabetes risk assessment in UK Biobank and MESA cohorts
- Meta-analysis suggests Hatha yoga may improve blood pressure and glucose in non-communicable disease patients